Both proteins increased peak plasma insulin concentrations in prediabetic persons by 96 % compared with MD19 ( each , P < 0.05 ) , which was accompanied by a reduction of peak venous blood glucose by 21 % ( each , P < 0.0001 ) without a difference between the 2 proteins .